stockrowSurgery Partners, Inc.
SGRY Healthcare Medical Care Facilities
Surgery Partners, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 6.24% from fiscal 2024.
- Revenue
- +2.75%
- EPS
- −500.0%
- Free cash flow
- −60.6%
- Total debt
- +4.92%
Quarter to June 2026, against a year earlier
Follow SGRY
Alert me
Surgery Partners, Inc. (SGRY) EPS (diluted)
Surgery Partners, Inc.'s EPS (diluted) for fiscal 2025 was −$0.61, compared with −$1.33 in fiscal 2024. Over the twelve months to 30 June 2026 it was −$0.70. Over the past ten years it has ranged from −$4.96 (fiscal 2018) to $0.20 (fiscal 2016); the current reading is higher than 64% of that period. Surgery Partners, Inc. ranks 38th of 48 Medical Care Facilities companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$0.61 | — |
| FY2024 | −$1.33 | — |
| FY2023 | −$0.09 | — |
| FY2022 | −$0.59 | — |
| FY2021 | −$1.12 | — |
| FY2020 | −$3.19 | — |
| FY2019 | −$2.27 | — |
| FY2018 | −$4.96 | — |
| FY2017 | −$1.64 | — |
| FY2016 | $0.20 | 400.00% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | −$0.12 | — |
| Mar 2026 | −$0.28 | — |
| Dec 2025 | −$0.12 | — |
| Sep 2025 | −$0.18 | — |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| NHC National HealthCare Corporation compare | $7.24 |
| ADUS Addus HomeCare Corporation compare | $6.00 |
| MD Pediatrix Medical Group, Inc. compare | $1.84 |
| AVAH Aveanna Healthcare Holdings Inc. compare | $1.23 |
| GRDN Guardian Pharmacy Services, Inc. compare | $1.03 |
| ASTH Astrana Health, Inc. compare | $0.82 |
| BKD Brookdale Senior Living Inc. compare | −$0.58 |
| SGRY Surgery Partners, Inc. | −$0.70 |
| ACHC Acadia Healthcare Company, Inc. compare | −$12.47 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on SGRY
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement